Navigation Links
Carefx Named an Innovative Information Access 'Company to Watch' By Leading Market Research Firm
Date:10/28/2009

for Software and Services, IDC. "Innovative solutions are coming from a group of young companies with fresh approaches to access and manage all types of information. These innovations are having their impact on the industry and will spur technology growth in the coming years."

The "Companies to Watch" report (IDC #220450) stated that Carefx's Fusionfx Solution Suite is a noteworthy strategy because it uses a graphical, role-based portal system to provide an innovative and secure way for healthcare organizations to connect and integrate data sources and applications within healthcare organizations.

(IDC's "Companies to Watch" reports are a qualitative evaluation of a set of vendors within a specific market - they are not a stack ranking nor do they represent an exhaustive evaluation of all companies in a segment or a comparative ranking of the companies in the report.)

Fusionfx, now in use at more than 600 organizations across North America and Europe, including The Johns Hopkins Health System, Virginia Mason Medical Center, Fletcher Allen Health Care, Boston Medical Center, Trillium Health Centre, Catholic Healthcare West and Cambridge University Hospitals, streamlines clinical and business workflow and connects providers to needed information by managing care transitions and information gaps between diverse systems, departments and facilities.

In addition, Carefx is ranked #166 on Deloitte's 2009 Technology Fast 500(TM), Deloitte LLP's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America, based on percentage of fiscal year revenue growth during the five year period from 2004-2008. Carefx grew 807 percent during that period. For more information on Deloitte's 2009 Technology Fast 500, visit http://www.deloitte.com/us/fast500/.

For more information on "I
'/>"/>

SOURCE Carefx Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Carefxs New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients
2. Top Healthcare Magazine Awards Carefx Client 2009 IT Project of the Year
3. Carefx Implements Fusionfx at Fletcher Allen Health Care to Improve Anywhere/Anytime Access to Crucial Patient Information
4. Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite
5. Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite
6. Virginia Mason Signs with Carefx to Implement Fusionfx Solution Suite
7. Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making
8. Carefxs Newest White Paper Illuminates Healthcare CIOs Growing Role in Operations, Strategic Thinking and IT Project Decision Making
9. Carefx Expands International Presence with New Office in London
10. Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable
11. Enloe Medical Center Partners with Carefx to Help Clinicians Quickly, Easily Access Diverse Patient Information

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , Sinusitis patients lif...nic sinusitis, Sinus Dynamics non-invasive nasal s...venience of treating all types of Sinusitis withou...ny sinus surgery. Researchers found 82.9% of patie...ized antibiotics with mean particle diameter of 3....
(Date:11/24/2009)... ,, WASHINGTON,Nov.24/PRNewswire-USNewswire/...hofthenearly4millionAmericansinfectedwithchroniche...yearsshouldbeawake-upcallthatCongressneedstomoveur...eddetection,research,andsurveillanceefforts,the Na..., TheNVHRwarnsthatwithoutcongressionalaction,mil...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)... , After suffering from w...losi,s hair is growing back and she,s sharing her ...ousands of other women through the release of her ... her hair before and during her treatment. , ...- Long-time hair loss sufferer Zsanett Siklosi h...
(Date:11/23/2009)... ,, HATBORO,Pa.,Nov.23/PRNewswire-FirstCall/...providerofenterprisemobilitysolutionsforthehealthc...y,formerVicePresidentofManagedServicesatSiemensHea...ategicHealthcareServices. ,, (Logo: http://www...., AsVicePresidentofStrategicHealthcareServicesfo...
Breaking Medicine News(10 mins):Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3
... Air Products (NYSE: APD ) announced today that ...hn E. McGlade will be presenting at the Goldman Sa...sday, June 4, 2009, at 8:00 a.m. EDT. , , An aud...tm . , , Air Products (NYSE: APD ) serves cust...
...Sally Kwak, economics professors at the University... Economics and Human Biology titled, "Weight Gai...amines trends in adolescent body mass index (BMI) ...ir friends, even after controlling for confounding...
... SMOS, has just passed the all-important Flight Ac...that make up the mission are in place for launch l...for its journey to the Plesetsk Cosmodrome in nort...ements not only include the satellite, but also th...
...t Work, the first company to enable physician serv...icine technology, has secured full-time physician ...ed by emergency medicine and internal medicine phy...bines innovative medical instruments, telecommunic...
... 28 Transcept Pharmaceuticals, Inc. (Nasdaq: TS...n the development and commercialization of proprie...eeds in the field of neuroscience, announced today...k City on Wednesday, June 10, 2009 at 3:00 p.m., E...
...sue of Ostomy Wound Management(1) , , SKILLMAN, ...le living with an ostomy reported very high levels...pioneered by ConvaTec Ostomy Care, according to re...technologies for community and hospital care, deve...
Other Medicine News:Health News:SMOS ready to ship to launch site 2Health News:Not Feeling Well? Can't Leave the Office? The Doctor Will See You Now 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 3Health News:Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier 2Health News:Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier 3Health News:Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier 4
(Date:11/23/2009)...3/PRNewswire/--TwooftheChicagoarea,sleadingBoardCe...inwomen,sbreastimaging,couplingthelatesttechnology...soundwiththeabilitytohavethefullrangeofdigitalimag...foresheleavestheoffice.Drs.AhmedFaragandJoanWerber...hecurrent6-9monthwaitforanappointmentcommonlyfound...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...hiefExecutiveOfficer,andMichaelJ.Lambert,Executive...topresentatthe21stAnnualPiperJaffrayHealthCareConf...day,December2,2009,at10:00a.m.ET.Mr.LukianovandMr....
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq:...t-reagentsystemstothebloodtransfusionindustry,toda...fray21stAnnualHealthCareConferenceinNewYork,NYwill...Company,spresentationisscheduledforTuesday,Decembe...tionwillbeavailablethroughthe"AboutUs--InvestorInf...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 32009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 12009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 1Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 2
... Program for Oral Compounds,to Treat Alcohol Depe...2, 2007--Alkermes, Inc.,(Nasdaq: ALKS) today annou...trial of ALKS 29 in alcohol dependent patients. Ba...rward with its,development program for oral produc...is a combination of two agents with distinct,pharm...
...07 -- DOR BioPharma, Inc.,(OTCBB: DORB) ("DOR" or ...lts from testing of a multivalent form of its botu...lished in the journal,Infection and Immunity (Ravi...75, p. 3043 ). These results are the first that,de...valent vaccine,that is active by the mucosal route...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6
Chemstrip Micral
QED A350 Saliva Alcohol Test
AccuSign DOA Series Tests
...highly accurate in detecting the presence of drugs... GC/MS testing. This assay provides a preliminary ...uch as GC/MS) must be used in order to obtain a co...plied to any drug of abuse test result, particular...
Medicine Products: